(Q52503143)
Statements
Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. (English)
Neuwelt EA
Diehl JT
Vu LH
Hill SA
Michael AJ
Frenkel EP
1 April 1981
94
4 pt 1
449-454